KARPAS 299(人間變性大細(xì)胞淋巴瘤細(xì)胞株)
CBP60271
詢 價(jià)
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
I. General information | |
Synonyms: | KARPAS 299 |
Background: | A human T cell lymphoma cell line established from the peripheral blood of a 25-year-old man with T cell non-Hodgkin's lymphoma in 1986; now classed as CD30+ anaplastic large cell lymphoma (ALCL); cells carry the NPM-ALK fusion gene. |
Species: | human (Homo sapiens) |
Tissue: | Lymphoma |
Disease: | Human Non-Hodgkin's Ki-positive Large Cell Lymphoma |
Gender: | 25-year-old, male |
Morphology: | Lymphoblastoid |
Growth Mode: | Suspension |
Doubling Time: | N/A |
DNA Profile: | Amelogenin: X,Y CSF1PO: 10,11 D13S317: 8,12 D16S539: 12 D5S818: 11,12 D7S820: 10,11 THO1: 7,8.3 TPOX: 8 vWA: 17,19 Cobioer’s Cell Line Authentication Service |
Culture Medium: |
RPMI-1640+10%FBS KARPAS 299完全培養(yǎng)基,# CBP60271M |
Cryopreservation medium: | 90%FBS+10%DMSO |
Karyotype: | Hypodiploid |
Subculture Routine: | Maintain cultures between 0.5 - 2 x1000,000 cells/ml; 5% CO2; 37°C. Doubling time approximately 30 hours. Split saturated culture 1:3 every 2-3 days. Round to polygonal cells growing singly or in small clusters in suspension. |
Comments: | For more information, please contact Cobioer (4008-750-250). |